Clinical Trial Update: Long-term Safety of TPN171H Tablet in Erectile Dysfunction. [Phase 3]

View source ↗

Summary

Phase 3 study assessing the long-term safety of TPN171H Tablet for erectile dysfunction has completed; the update summarizes the long-term safety findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• TPN171H Tablet (TPN171H)

Snippet

Sponsor: Vigonvita Life Sciences | Conditions: Erectile Dysfunction | Phase 3 | Status: COMPLETED